| 000 | 00982 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517063941.0 | ||
| 264 | 0 | _c20160826 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a2211-0356 | ||
| 024 | 7 |
_a10.1016/j.msard.2015.07.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLevy, Michael | |
| 245 | 0 | 0 |
_aThe ethics of placebo controlled clinical trials in NMO - A balance of risks. _h[electronic resource] |
| 260 |
_bMultiple sclerosis and related disorders _cNov 2015 |
||
| 300 |
_a512-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 |
_aControlled Clinical Trials as Topic _xethics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aNeuromyelitis Optica _xdrug therapy |
| 773 | 0 |
_tMultiple sclerosis and related disorders _gvol. 4 _gno. 6 _gp. 512-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.msard.2015.07.016 _zAvailable from publisher's website |
| 999 |
_c25469762 _d25469762 |
||